Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction

被引：0
|
作者：
H L Neville-Webbe
R E Coleman
I Holen
机构：
[1] Academic Unit of Clinical Oncology,
[2] Cancer Research Centre,undefined
[3] Weston Park Hospital,undefined
来源：
British Journal of Cancer | 2010年 / 102卷
关键词：
zoledronic acid; letrozole; apoptosis; synergy; breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1010 / 1017
页数：7
相关论文
共 50 条
  • [1] Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction
    Neville-Webbe, H. L.
    Coleman, R. E.
    Holen, I.
    [J]. BRITISH JOURNAL OF CANCER, 2010, 102 (06) : 1010 - 1017
  • [2] Mechanisms of the synergistic interaction between the bisphosphonate zoledronic acid and the chemotherapy agent paclitaxel in breast cancer cells in vitro
    Neville-Webbe, HL
    Evans, CA
    Colemana, RE
    Holen, I
    [J]. TUMOR BIOLOGY, 2006, 27 (02) : 92 - 103
  • [3] In vitro synergistic cytoreductive effects of zoledronic acid and radiation on breast cancer cells
    Ural, A. Ugur
    Avcu, Ferit
    Candir, Muhammed
    Guden, Metin
    Ozcan, M. Ali
    [J]. BREAST CANCER RESEARCH, 2006, 8 (04)
  • [4] Synergistic activity of the histone deacetylase inhibitor suberoylanilide hydroxamic acid and the bisphosphonate zoledronic acid against prostate cancer cells in vitro
    Sonnemann, Juergen
    Bumbul, Beata
    Beck, James F.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2007, 6 (11) : 2976 - 2984
  • [5] Zoledronic acid (ZOL) and letrozole (LET) induce synergistic levels of apoptosis in breast cancer cells
    Neville-Webbe, HL
    Lefley, D
    Coleman, RE
    Holen, I
    [J]. BONE, 2006, 38 (03) : S58 - S59
  • [6] Does inhibition of aromatase by the specific inhibitor letrozole radiosensitize human breast cancer cells in vitro?
    Schmid-Bielenberg, D.
    Ohneseit, P. A.
    Krebiehl, G.
    Rodemann, H. P.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 : 79 - 79
  • [7] The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel
    S P Jagdev
    R E Coleman
    C M Shipman
    A Rostami-H
    P I Croucher
    [J]. British Journal of Cancer, 2001, 84 : 1126 - 1134
  • [8] The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel
    Jagdev, SP
    Coleman, RE
    Shipman, CM
    Rostami-H, A
    Croucher, PI
    [J]. BRITISH JOURNAL OF CANCER, 2001, 84 (08) : 1126 - 1134
  • [9] Combined effects of neoadjuvant letrozole and zoledronic acid on γδT cells in postmenopausal women with early-stage breast cancer
    Sugie, Tomoharu
    Suzuki, Eiji
    Yamauchi, Akira
    Yamagami, Kazuhiko
    Masuda, Norikazu
    Gondo, Naomi
    Sumi, Eriko
    Ikeda, Takafumi
    Tada, Harue
    Uozumi, Ryuji
    Kanao, Shotaro
    Tanaka, Yoshimasa
    Hamazaki, Yoko
    Minato, Nagahiro
    Toi, Masakazu
    [J]. BREAST, 2018, 38 : 114 - 119
  • [10] Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro
    Han Qiao
    Ting-yu Wang
    Wei Yan
    An Qin
    Qi-ming Fan
    Xiu-guo Han
    Yu-gang Wang
    Ting-ting Tang
    [J]. Acta Pharmacologica Sinica, 2015, 36 : 1085 - 1098
12345